<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0704257189
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2020
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        VINBLASTINE SULPHATE 10MG-10ML VIAL
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        VINBLASTINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        10
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Vial
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store in a refrigerator (2°c – 8°c)
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        504.55
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="HOSPIRA AUSTRALIA " />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            HOSPIRA AUSTRALIA 
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 2657]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Pfizer Saudi Trading
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            HOSPIRA UK LIMITED
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        L01CA01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Vinblastine sulphate is an anti-cancer medicine. Treatment with an anti-cancer medicine is sometimes called cancer chemotherapy.</p><p>&nbsp;</p><p>Vinblastine Sulphate solution for injection is sometimes used in the treatment of cancers of the lymph nodes, spleen, bone marrow, testicles, placenta, kidney and breast. It may be given alone or in combination with other anti-cancer medicines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Vinblastine Sulphate solution for injection must never be injected intrathecally (into the spine). Vincristine Sulphate solution for injection is for intravenous use only.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Do not use Vinblastine Sulphate solution for injection:</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if you are allergic to vinblastine or to any of the other ingredients of this medicine (listed in section 6)</p><ul><li>if you have a bacterial infection which is not under control</li><li>if your blood tests show that you do not have enough white blood cells to fight infection (unless this is a result of your condition being treated)</li></ul><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor, pharmacist or nurse before using Vinblastine Sulphate solution for injection</p><ul><li>if you are an elderly patient in poor health or with skin sores</li><li>if you have liver disease, including inflammation of the liver (hepatitis) or yellowing of your skin or the whites of your eyes (jaundice).</li></ul><p>&nbsp;</p><p>If you notice any of the following, and they do not go away, this might also mean that you have liver problems:</p><ul><li>Loss of appetite</li><li>Feeling itchy</li><li>Feeling tired, having no energy or feeling like you have flu</li><li>Feeling as though you are going to be sick or actually being sick</li></ul><p>&nbsp;</p><p>If in doubt, check with your doctor.</p><p>&nbsp;</p><p><strong>Other medicines and Vinblastine Sulphate solution for injection</strong></p><p>&nbsp;</p><p>Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.</p><p>&nbsp;</p><p>Special care is needed if you are taking/using other medicines as some could interact with vinblastine sulphate, for example:</p><ul><li>the use of mitomycin-C with or without progesterone (anti-cancer medicines), with vinblastine may cause severe breathing problems especially if you have a pre-existing heart condition</li><li>the use of bleomycin or cisplatin (anti-cancer medicines) with vinblastine may cause heart and circulation problems (e.g. Raynaud&rsquo;s phenomenon), worsening of low white blood cell counts, decrease in kidney function, affect the nervous system, hearing problems, impaired balance and changes to sperm motility.</li><li>the use of erythromycin (antibiotic) may increase the side effects of vinblastine such as low levels of white blood cells, muscle pain and constipation.</li><li>vinblastine may reduce the effectiveness of medicines used to treat epilepsy (e.g. phenytoin)</li><li>if you are having radiotherapy in the liver area your doctor will delay giving you vinblastine</li></ul><p><strong>&nbsp;</strong></p><p>The absence of menstruation (missing one or more menstrual periods) has occurred when Vinblastine Sulphate solution for injection has been used in combination with other drugs.</p><p>&nbsp;</p><p><strong>Pregnancy, breast-feeding and fertility</strong></p><p><strong>&nbsp;</strong></p><p>Tell your doctor if you are pregnant, trying to become pregnant or breast-feeding. Your doctor will decide if you should receive this medicine.</p><p>&nbsp;</p><p>As there is a risk of birth defects, women of childbearing potential should use appropriate contraception methods during treatment with vinblastine sulphate.</p><p><strong>&nbsp;</strong></p><p>If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.</p><p><strong>&nbsp;</strong></p><p><strong>Driving and using machines</strong></p><p>Do not drive or use machines if you experience any side effect which may lessen your ability to do so.</p><p><strong>&nbsp;</strong></p><p><strong>Vinblastine Sulphate solution for injection contains sodium</strong></p><p>This medicinal product contains 35.42 mg of sodium (main component of cooking/table salt) in each 10ml vial. This is equivalent to 1.77% of the recommended maximum daily dietary intake of sodium for an adult.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>This medicine is given by injection (using a mini-bag infusion) into a vein. Alternatively, it may be injected into the line of a running infusion (drip). Never be injected intrathecally (into the spine).</p><p>&nbsp;</p><p>VinBLAStine sulphate is an irritant, if it accidentally gets into your eyes tell your doctor or nurse immediately so that it may be washed out.</p><p>&nbsp;</p><p>You may be given medicines to prevent nausea and vomiting during treatment with VinBLAStine sulphate.</p><p>&nbsp;</p><p><strong>Dosage</strong></p><p>Your doctor will work out the correct dose of VinBLAStine sulphate for you and how often it must be given.&nbsp;</p><p>&nbsp;</p><p>The dose will depend on your medical condition, your size and how well your liver is working. Your doctor will tell how well your liver is working using a blood sample. If your liver is not working properly the dose may be reduced.</p><p>&nbsp;</p><p>VinBLAStine sulphate is usually given once a week or less.</p><p>&nbsp;</p><p><strong>If you are given too much or too little VinBLAStine Sulphate solution for injection</strong></p><p>This medicine will be given to you in a hospital, under the supervision of a doctor. It is unlikely that you will be given too much or too little, however, tell your doctor or nurse if you have any concerns.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can have side effects, although not everybody gets them.</p><p>&nbsp;</p><p><strong>If any of the following happen, tell your doctor immediately:</strong></p><ul><li>severe allergic reaction &ndash; you may experience a sudden itchy rash (hives), swelling of the hands, feet, ankles, face, lips, mouth or throat (which may cause difficulty in swallowing or breathing), and you may feel you are going to faint.</li></ul><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; pain or swelling at the injection site during or immediately after the injection</p><p>&nbsp;</p><p>These are serious side effects. You may need urgent medical attention.</p><p>&nbsp;</p><p><strong>If any of the following happen, tell your doctor as soon as possible.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Not known: frequency cannot be estimated from the available data</strong></p><ul><li>low blood cell count which may be present as anaemia, fever or infection, abnormal bleeding or bruising</li><li>convulsions (fits)</li><li>blood in the stools which may be accompanied by abdominal pain</li><li>blistering of the skin, skin ulcers</li><li>mouth ulcers</li><li>sore throat</li><li>significant weight loss</li><li>dizziness</li><li>numbness or pins and needles</li><li>changes or loss of your tendon reflexes tested by tapping your tendon</li><li>mental depression</li><li>stomach cramps, pain in the abdomen, constipation or diarrhoea</li><li>nausea or vomiting</li><li>loss of appetite&nbsp;</li><li>pain where the tumour is</li><li>pain in your bones or muscles or jaw</li><li>headache</li><li>deafness or hearing difficulty which may be temporary or permanent hearing difficulty</li><li>problems with your balance</li><li>uncontrolled movements of the eyes, usually from side to side</li><li>severe chest pain</li><li>heart attack or stroke</li><li>high blood pressure</li><li>shortness of breath</li><li>dry cough</li><li>weakness</li><li>tiredness and generally feeling unwell</li><li>hair loss</li><li>a reduction in the production of semen and motility of semen</li><li>reaction at injection site</li></ul><p>&nbsp;</p><p>VinBLAStine sulphate may lead to changes in your blood cells. Your doctor will take blood samples to monitor for these and also to check how well your liver is working.</p><p>&nbsp;</p><p><strong>Reporting of side effects</strong></p><p>If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine.</p><p>&nbsp;</p><p>To Report side effects:</p><p>&nbsp;</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre (NPC)</p><ul><li>Call center: 19999</li><li>E-mail: npc.drug@sfda.gov.sa</li><li>Website: www.sfda.gov.sa/npc</li></ul></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep this medicine out of the sight and reach of children.</p><p><strong>&nbsp;</strong></p><p>Do not use this medicine after the expiry date which is stated on the vial label and carton after &#39;EXP&#39;. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Store in a refrigerator (2&deg;C - 8&deg;C). Keep the vial in outer carton in order to protect from light.</p><p>&nbsp;</p><p>From a microbiological point of view, the diluted product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8&deg;C, unless dilution has taken place in controlled and validated aseptic conditions.</p><p>&nbsp;</p><p>Do not use this medicine if you notice evidence of precipitation or any other particulate matter.</p><p>&nbsp;</p><p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is vinblastine sulphate. Each millilitre (ml) of solution contains 1 milligram (mg) of vinblastine sulphate.</p><p>&nbsp;</p><p>The other ingredients are sodium chloride and water for injections (see section 2 <strong>VinBLAStine Sulphate solution for injection contains sodium</strong>).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                VinBLAStine Sulphate solution for injection is a clear, colourless solution which comes in glass containers called vials. 

It is supplied in packs containing 5 x 10 mg/10ml vials. 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder </strong></p><p>Hospira UK Limited</p><p>Horizon</p><p>Honey Lane</p><p>Hurley</p><p>Maidenhead</p><p>SL6 6RJ</p><p><strong>&nbsp;</strong></p><p><strong>Manufacturer </strong></p><p>Hospira Australia Pty Ltd&nbsp;MULGRAVE, Australia</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                July 2023
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">سلفات فينبلاستين هو دواء مضاد للسرطان. وفي بعض الأحيان، يُطلق على العلاج باستخدام دواء مضاد للسرطان مصطلح العلاج الكيميائي للسرطان.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يستخدم محلول سلفات فينبلاستين المخصص للحقن أحيانًا في علاج سرطانات العقد الليمفاوية والطحال ونخاع العظم والخصيتين والمشيمة والكلى والثدي.&nbsp; ويمكن إعطاؤه بمفرده أو بالتزامن مع أدوية أخرى مضادة للسرطان.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL"><strong>يجب ألا يُحقن محلول سلفات فينبلاستين المخصص للحقن داخل القراب (داخل العمود الفقري) أبدًا. ويُستخدم محلول سلفات فينبلاستين المخصص للحقن عن طريق الوريد فقط.</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>موانع استعمال محلول سلفات فينبلاستين المخصص للحقن:</strong></p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; إذا كنت مصابًا بالحساسية تجاه فينبلاستين أو أي من المكونات الأخرى لهذا الدواء (مدرجة في القسم ٦).</p><ul><li dir="RTL">إذا كنت مصابًا بعدوى بكتيرية غير متحكم بها</li><li dir="RTL">إذا أظهرت فحوص الدم الخاصة بك أنه لا يوجد لديك ما يكفي من خلايا الدم البيضاء لمحاربة العدوى (ما لم يكن ذلك نتيجة حالتك التي يتم علاجها)</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الاحتياطات عند استعمال محلول سلفات فينبلاستين المخصص للحقن</strong></p><p dir="RTL">استشر طبيبك، أو الصيدلي، أو الممرضة قبل استخدام محلول سلفات فينبلاستين المخصص للحقن</p><ul><li dir="RTL">إذا كنت مريضًا مسنًّا وصحتك معتلة أو تعاني من تقرحات جلدية</li><li dir="RTL">إذا كنت مصابًا بمرض في الكبد، بما في ذلك التهاب الكبد (التهاب الكبد الوبائي) أو اصفرار لون جلدك أو بياض عينيك (اليرقان).</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لاحظت أيًا من الأعراض التالية، وكانت لا تزول، فهذا قد يعني أيضًا أنك تعاني من مشكلات في الكبد:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فقدان الشهية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالحكة</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور بالتعب وبانعدام الطاقة أو الشعور كما لو كنت مصابًا بالإنفلونزا</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الشعور كما لو أنك على وشك التقيؤ أو التقيؤ بالفعل</p><p dir="RTL">&nbsp;</p><p dir="RTL">راجع طبيبك إذا لم تكن متأكدًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>&zwnj;التداخلات الدوائية مع أخذ هذا المستحضر مع أي أدوية أخرى أو أعشاب أو مكملات غذائية.</strong></p><p dir="RTL">أخبر طبيبك، أو الصيدلي، أو الممرضة عما إذا كنت تتناول حاليًا أي أدوية أخرى أو تناولت مؤخرًا أو قد تتناول.</p><p dir="RTL">يجب توخي الحذر بشكل خاص إذا كنت تتناول/تستخدم أدوية أخرى نظرًا لأن بعض تلك الأدوية يمكن أن تتفاعل مع سلفات فينبلاستين، على سبيل المثال:</p><ul><li dir="RTL">يمكن أن يتسبب استخدام ميتومايسين-سي مع بروجيستيرون (أدوية مضادة للسرطان) أو من دونه بالتزامن مع فينبلاستين في حدوث مشكلات شديدة في التنفس، خاصةً إن كنت تعاني من حالة قلبية موجودة مسبقًا</li><li dir="RTL">يمكن أن يتسبب استخدام بليومايسين أو سيسبلاتين (أدوية مضادة للسرطان) بالتزامن مع فينبلاستين في حدوث مشكلات في القلب والدورة الدموية (مثل ظاهرة رينو)، وتفاقم انخفاض تعداد خلايا الدم البيضاء، وانخفاض في وظائف الكليتين، والتأثير في الجهاز العصبي، وحدوث مشكلات في السمع، وخلل التوازن، وتغيرات في حركة الحيوانات المنوية.</li><li dir="RTL">يمكن أن يتسبب استخدام إريثرومايسين (مضاد حيوي) في زيادة الأعراض الجانبية لفينبلاستين، مثل انخفاض مستويات خلايا الدم البيضاء، وألم العضلات، والإمساك.</li><li dir="RTL">يمكن أن يقلل فينبلاستين من فعالية الأدوية المستخدمة لعلاج الصرع (مثل فينيتوين)</li><li dir="RTL">إذا كنت تخضع لعلاج بالإشعاع في منطقة الكبد، فسيقوم طبيبك بتأجيل إعطائك فينبلاستين</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">حدث غياب نزول الحيض (انقطاع دورة شهرية واحدة أو أكثر) عند استخدام محلول سلفات فينبلاستين المخصص للحقن بالتزامن مع عقاقير أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الحمل والرضاعة الطبيعية والخصوبة</strong></p><p dir="RTL">أخبري طبيبكِ إذا كنتِ حاملًا أو تحاولين الحمل أو ترضعين رضاعة طبيعية. وسيقرر طبيبكِ إذا كان ينبغي أن تتلقي هذا الدواء أم لا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">نظرًا لوجود خطر حدوث عيوب ولادية، ينبغي على السيدات القادرات على الإنجاب أن يستخدمن وسائل مناسبة لمنع الحمل أثناء العلاج بسلفات فينبلاستين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا كنتِ حاملًا أو ترضعين رضاعة طبيعية، أو تعتقدين أنكِ قد تكونين حاملًا أو تخططين للحمل، فاستشيري طبيبكِ أو الصيدلي قبل استخدام هذا الدواء.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تأثير محلول سلفات فينبلاستين المخصص للحقن على القيادة واستخدام الآلات</strong></p><p dir="RTL">لا تقم بالقيادة أو استخدام الآلات إذا أصبت بأي أعراض جانبية قد تحد من قدرتك على فعل ذلك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>معلومات هامة حول بعض مكونات محلول سلفات فينبلاستين المخصص للحقن</strong></p><p dir="RTL"><strong>يحتوي محلول سلفات فينبلاستين المخصص للحقن على الصوديوم</strong></p><p dir="RTL">يحتوي هذا المنتج الدوائي على ۳٥,٤۲ ملجم من الصوديوم (المكون الرئيس لملح المائدة/الطعام) بكل قارورة سعة ۱۰ مل، وهو ما يكافئ ۱,٧٧% من الحد الأقصى الموصى به للمدخول الغذائي اليومي من الصوديوم للشخص البالغ.</p></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">يُعطى هذا الدواء عن طريق الحقن (باستخدام كيس تسريب صغير) في أحد الأوردة.&nbsp; وبدلًا من ذلك، يمكن أن يُحقن داخل خط تسريب (تنقيط) متدفق. يجب ألا يُحقن داخل القراب (داخل العمود الفقري) أبدًا.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يُعتبر سلفات فينبلاستين مادة مهيجة، ولذلك إذا دخل إلى عينيك عن طريق الخطأ يجب عليك إبلاغ طبيبك أو الممرضة بذلك على الفور حتى يتم غسله.</p><p dir="RTL">&nbsp;</p><p dir="RTL">قد يتم إعطاؤك أدوية لمنع الغثيان والقيء أثناء العلاج بسلفات فينبلاستين.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة</strong></p><p dir="RTL">سيحدد طبيبك مقدار الجرعة الصحيحة لك من سلفات فينبلاستين، وكذلك المعدل الواجب إعطاؤك الدواء وفقًا له.&nbsp;</p><table cellspacing="0" cellpadding="0" align="center"><tbody><tr><td style="vertical-align:top"><p dir="RTL">وسيعتمد مقدار الجرعة على حالتك الطبية وحجمك ومدى كفاءة عمل كبدك. سيتمكن طبيبك من معرفة مدى كفاءة عمل كبدك باستخدام عينة دم يتم سحبها منك.&nbsp; ويمكن أن يتم تقليل الجرعة إذا لم يكن كبدك يعمل كما ينبغي.</p><p dir="RTL">&nbsp;</p><p dir="RTL">عادةً ما يُعطى سلفات فينبلاستين بمعدل مرة واحدة أسبوعيًا أو أقل.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الجرعة الزائدة من محلول سلفات فينبلاستين المخصص للحقن</strong></p><p dir="RTL">سيتم إعطاء هذا الدواء لك في مستشفى، وتحت إشراف طبيب.&nbsp; ومن غير المرجح أن يتم إعطاؤك كمية أكبر أو أقل مما ينبغي، ومع ذلك، أخبر طبيبك أو الممرضة إذا كانت لديك أي مخاوف.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&nbsp;</p></td></tr></tbody></table></td></tr></tbody></table>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">كما هو الحال بالنسبة لجميع الأدوية، يمكن أن تكون لهذا الدواء أعراض جانبية، إلا أنها لا تصيب الجميع.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا حدث أي مما يلي، فأخبر طبيبك على الفور:</strong></p><ul><li dir="RTL">تفاعل حساسية شديد - قد تصاب بطفح جلدي مفاجئ مثير للحكة وتورم في اليدين أو القدمين أو الكاحلين أو الوجه أو الشفتين أو الفم أو الحلق (مما قد يسبب صعوبة في البلع أو التنفس) وقد تشعر بأنك على وشك الإصابة بالإغماء.</li></ul><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم أو تورم في موضع الحقن، أثناء الحقن أو بعده مباشرة</p><p dir="RTL">&nbsp;</p><p dir="RTL">تُعد هذه الأعراض الجانبية خطيرة. وقد تحتاج إلى عناية طبية عاجلة في حال حدوثها.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>إذا حدث أي مما يلي، فأخبر طبيبك في أسرع وقت ممكن.</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>معدل التكرار غير معروف: لا يمكن تقدير معدل التكرار من خلال البيانات المتاحة</strong></p><ul><li dir="RTL">انخفاض تعداد خلايا الدم الذي قد يكون موجودًا في صورة فقر الدم أو الحمى أو العدوى أو النزيف غير الطبيعي أو التكدم</li><li dir="RTL">التشنجات (النوبات)</li><li dir="RTL">وجود دم في البراز قد يكون مصحوبًا بألم في البطن</li><li dir="RTL">تبثر الجلد، قرح الجلد</li><li dir="RTL">قرح الفم</li><li dir="RTL">التهاب الحلق</li><li dir="RTL">فقدان الوزن بشكل ملحوظ</li><li dir="RTL">الدوار</li><li dir="RTL">الخدر أو الإحساس بالشكشكة والوخز</li><li dir="RTL">تغيرات في المنعكسات الوترية أو فقدانها، ويتم اختبار ذلك عن طريق النقر على أوتارك</li><li dir="RTL">الاكتئاب العقلي</li><li dir="RTL">تقلصات المعدة أو ألم في البطن أو إمساك أو إسهال</li><li dir="RTL">الغثيان أو القيء</li><li dir="RTL">فقدان الشهية&nbsp;</li><li dir="RTL">ألم في مكان الورم</li><li dir="RTL">ألم في عظامك أو عضلاتك أو فكك</li><li dir="RTL">الصداع</li><li dir="RTL">الصمم أو صعوبة السمع التي قد تكون مؤقتة أو دائمة</li><li dir="RTL">مشكلات في التوازن</li><li dir="RTL">حركات لا يمكن التحكم بها للعينين، وعادةً ما تكون من جانب إلى آخر</li><li dir="RTL">ألم الصدر الشديد</li><li dir="RTL">الأزمة القلبية أو السكتة الدماغية</li><li dir="RTL">ارتفاع ضغط الدم</li><li dir="RTL">ضيق التنفس</li><li dir="RTL">السعال الجاف</li><li dir="RTL">الضعف</li><li dir="RTL">التعب وشعور عام بالتوعك</li><li dir="RTL">فقدان الشعر</li><li dir="RTL">انخفاض إنتاج السائل المنوي وقلة حركته</li><li dir="RTL">تفاعلات في موضع الحقن</li></ul><p dir="RTL">&nbsp;</p><p dir="RTL">يمكن أن يتسبب سلفات فينبلاستين في حدوث تغيرات في خلايا دمك. سيقوم طبيبك بسحب عينات دم منك لرصد هذه التغيرات، وكذلك للتحقق من مدى كفاءة عمل كبدك.</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>الإبلاغ عن الأعراض الجانبية</strong></p><p dir="RTL">إذا أصبت بأي أعراض جانبية، فتحدث إلى طبيبك، أو الصيدلي، أو الممرضة بشأنها. يشمل هذا أي أعراض جانبية محتملة غير مدرجة في هذه النشرة. بالإبلاغ عن الأعراض الجانبية، يمكنك المساعدة في توفير المزيد من المعلومات حول سلامة هذا الدواء.</p><p dir="RTL">للإبلاغ عن الأعراض الجانبية:</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>المملكة العربية السعودية</strong></p><p dir="RTL"><em>&nbsp;</em></p><table dir="rtl" border="0" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp; المركز الوطني للتيقظ الدوائي:</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; مركز الاتصال الموحد: ١٩٩٩٩</p><p dir="RTL">&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; البريد الالكتروني: npc.drug@sfda.gov.sa</p><p dir="RTL"><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em>الموقع الالكتروني: https://ade.sfda.gov.sa</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL"><strong><em>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </em></strong><strong>دول الخليج الأخرى</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><table dir="rtl" border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p dir="RTL">-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; رجاء الاتصال بالمؤسسات والهيئات الوطنية في كل دولة.</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">احفظ هذا الدواء بعيدًا عن مرأى ومتناول الأطفال.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم هذا الدواء بعد تاريخ انتهاء الصلاحية المدون على ملصق القارورة والعبوة الكرتونية بعد الرمز &quot;EXP&quot;.&nbsp; يشير تاريخ انتهاء الصلاحية إلى آخر يوم في الشهر المذكور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">خزّنه في الثلاجة (في درجة حرارة تتراوح بين درجتين مئويتين و۸ درجات مئوية). واحفظ القارورة في العبوة الكرتونية الخارجية من أجل حمايتها من الضوء.</p><p dir="RTL"><br />من وجهة نظر ميكروبيولوجية، ينبغي استخدام المنتج المخفف على الفور. وإذا لم يُستخدم فورًا، فإن مسؤولية الالتزام بمدد تخزين المحلول قيد الاستخدام وظروفه قبل استخدامه تقع على عاتق المستخدم، وعادةً لا تتجاوز مدة حفظه ۲٤ ساعة في درجة حرارة تتراوح بين درجتين مئويتين و۸ درجات مئوية، ما لم يتم التخفيف في ظروف تعقيم متحكم بها ومتحقق منها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تستخدم هذا الدواء إذا لاحظت دليلًا على وجود ترسب أو أي جسيمات أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا تتخلص من أي أدوية عبر مياه الصرف أو مع النفايات المنزلية. واسأل الصيدلي عن كيفية التخلص من الأدوية التي لم تعد تستخدمها. ستساعد هذه التدابير على حماية البيئة.</p><p dir="RTL">&nbsp;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">المادة الفعالة هي سلفات فينبلاستين. يحتوي كل ملليلتر (مل) من المحلول على۱ مليجرام (ملجم) من سلفات فينبلاستين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">المكونات الأخرى هي كلوريد الصوديوم وماء للحقن (انظر القسم ۲ &quot;<strong>يحتوي محلول سلفات فينبلاستين المخصص للحقن على الصوديوم&quot;)</strong>.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">محلول سلفات فينبلاستين المخصص للحقن هو محلول صاف عديم اللون يأتي في حاويات زجاجية تُسمى قوارير.</p><p dir="RTL" style="text-align:right">&nbsp;</p><p dir="RTL" style="text-align:right">ويتم توفيره في عبوات تحتوي على٥ قارورات x&rlm; ۱۰ ملجم/۱۰ مل.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>مالك رخصة التسويق </strong></p><p dir="RTL">Hospira UK Limited</p><p dir="RTL">Horizon</p><p dir="RTL">Honey Lane</p><p dir="RTL">Hurley</p><p dir="RTL">Maidenhead</p><p dir="RTL">SL6 6RJ</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>المصنع</strong></p><p dir="RTL">Hospira Australia Pty Ltd MULGRAVE, Australia</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            يوليو/تموز ۲۰۲۳.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Vinblastine Sulphate 1 mg/ml solution for injection
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 1 ml contains 1.0 mg of vinblastine sulphate.
	
	Each 10 ml presentation contains 10 mg of vinblastine sulphate.

	Excipient with known effect

	Vinblastine Sulphate 1 mg/ml solution for injection contains 35.42 mg sodium in each 10 ml vial.

	For the full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection.

A clear, colourless sterile solution.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Vinblastine sulphate is a cytotoxic drug that arrests cell growth at the metaphase. Its actions are more pronounced on the rapidly dividing cell than on the normal cell. It appears to act, like vincristine, by binding to the microtubular proteins of the mitotic spindle, preventing polymerisation.</p><p><strong>&nbsp;</strong></p><p>Information available at present suggests that vinblastine sulphate may be useful, either alone or in combination with other oncolytic drugs, for the treatment of: Hodgkin&rsquo;s disease; non-Hodgkin&rsquo;s lymphoma; carcinoma of the breast; methotrexate-resistant choriocarcinoma; renal cell carcinoma; testicular teratoma and seminoma; histiocytosis X. Other neoplasms occasionally show a marked response to vinblastine sulphate, but less frequently than the more susceptible conditions listed above.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Posology</strong></p><p><strong>&nbsp;</strong></p><p>The recommended dose for adults, the elderly and children is 6 mg/m<sup>2</sup>, usually administered no more frequently than once every seven days. For testicular tumours, the dosage may be increased to 0.2 mg/kg administered on each of two consecutive days every three weeks.</p><p><strong>&nbsp;</strong></p><p>To minimise the possibility of extravascular spillage, it is suggested that the mini-bag infusion and needle be rinsed with venous blood before withdrawal. The dose should not be diluted in large volumes of diluent (ie, 100 to 250 ml) or given intravenously for prolonged periods (ranging from 30 to 60 minutes or more), since this frequently results in irritation of the vein and increases the chance of extravasation.</p><p>&nbsp;</p><p>Because of the enhanced possibility of thrombosis, it is considered inadvisable to inject a solution of VinBLAStine sulphate into an extremity in which the circulation is impaired, or potentially impaired, by such conditions as compressing or invading neoplasm, phlebitis or varicosity.</p><p>&nbsp;</p><p><strong>Patients with hepatic impairment</strong></p><p>&nbsp;</p><p>As VinBLAStine is excreted principally by the liver, toxicity may be increased when there is hepatic insufficiency, and it may be necessary to reduce initial doses in the presence of significantly impaired hepatic or biliary function. A reduction of 50% in the dose is recommended for patients having a direct serum bilirubin value above 3&nbsp;mg/100 ml.</p><p>&nbsp;</p><p><strong>Patients with renal impairment</strong></p><p>&nbsp;</p><p>Since metabolism and excretion are primarily hepatic, no modification is recommended for patients with impaired renal function.</p><p><strong>&nbsp;</strong></p><p><strong>VinBLAStine</strong><strong> should not be given intramuscularly, subcutaneously or intrathecally.</strong></p><p><strong>&nbsp;</strong></p><p><strong>Method of administration</strong></p><p><strong>&nbsp;</strong></p><p>The solution may be injected either directly into the vein or into the injection site of a running intravenous infusion. Injection of VinBLAStine sulphate may be completed in about one minute.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;</strong></p><p><strong>For intravenous use only.</strong></p><p><strong>Fatal if given by other routes</strong> (see section 4.4)</p><p>&nbsp;</p><p><strong>In case of mistaken administration by intrathecal route, see section 4.4.</strong></p><p>&nbsp;</p><p>To reduce the potential for fatal medication errors due to incorrect route of administration, VinBLAStine Sulphate solution for injection should be diluted in a flexible plastic container and prominently labeled as indicated <strong>&ldquo;FOR INTRAVENOUS USE ONLY&mdash; FATAL IF GIVEN BY OTHER ROUTES&rdquo;</strong></p><p>&nbsp;</p><p>Mini-bags infusion containing this product should be overlabelled with the intrathecal warning label provided - <strong>&#39;FOR INTRAVENOUS USE ONLY. FATAL IF GIVEN BY OTHER ROUTES&#39;.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

For intravenous use only. Fatal if given by other routes (see section 4.4).

VinBLAStine sulphate is contraindicated in patients who are leucopenic.

VinBLAStine sulphate should not be used in the presence of bacterial infection. Such infections should be brought under control with antiseptics or antibiotics before the initiation of therapy with VinBLAStine sulphate.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>VinBLAStine sulphate is for intravenous use only. VinBLAStine sulphate must be used only by physicians experienced in cytotoxic chemotherapy (see section 6.6).</p><p>&nbsp;</p><p>After inadvertent intrathecal administration of vinca alkaloids, immediate neurosurgical intervention is required in order to prevent ascending paralysis leading to death. In a very small number of patients, life‑threatening paralysis and subsequent death was averted but resulted in devastating neurological sequelae, with limited recovery afterwards.</p><p>The following treatment successfully arrested progressive paralysis in a single patient mistakenly given the related vincristine sulphate, intrathecally. This treatment should be initiated immediately:</p><p>&nbsp;</p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Removal of as much CSF as is safely possible through the lumbar access.</p><p>&nbsp;</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Flushing with Lactated Ringer&#39;s solution by continuous infusion at 150 ml/h, through a catheter in a cerebral lateral ventricle and removed through lumbar access, until fresh plasma became available.</p><p>&nbsp;</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fresh frozen plasma, 25 ml, diluted with 1litre of Lactated Ringer&#39;s was then infused similarly at 75 ml/h. The rate of infusion should be adjusted to maintain a spinal fluid protein level of 150 mg/dl.</p><p>&nbsp;</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Glutamic acid, 10 g, was given iv over 24 hours, followed by 500 mg tds by mouth for 1 month. Glutamic acid may not be essential.</p><p>&nbsp;</p><p><strong>VinBLAStine should not be given intramuscularly, subcutaneously or intrathecally.</strong></p><p><strong>&nbsp;</strong></p><p>Mini-bags infusion containing this product should be over labelled with the intrathecal warning label provided - <strong>&#39;FOR INTRAVENOUS USE ONLY. FATAL IF GIVEN BY OTHER ROUTES&#39;.</strong></p><p><strong>&nbsp;</strong></p><p>As with other antineoplastic agents, VinBLAStine may cause a severe local reaction on extravasation. If leakage into the surrounding tissue should occur during intravenous administration of VinBLAStine sulphate, the injection should be discontinued immediately and any remaining portion of the dose should be introduced into another vein. Local injection of hyaluronidase with the application of heat has been used to disperse the drug in order to minimise discomfort and the possibility of tissue damage. Cases of phlebitis and cellulitis have been reported.</p><p>Liver disease may alter the elimination of VinBLAStine in the bile, markedly increasing toxicity to peripheral nerves and necessitating a dosage modification in affected patients.</p><p>&nbsp;</p><p>&nbsp;</p><p>The dose-limiting factor is myelosuppression. In general, the larger the dose employed, the more profound and longer lasting the leucopenia will be. The fact that the granulocyte count returns to normal levels after drug‑induced leucopenia is an indication that the granulocyte-producing mechanism is not permanently depressed.</p><p>&nbsp;</p><p>Following therapy with VinBLAStine sulphate, the nadir in the granulocyte count may be expected to occur five to ten days after the last day of drug administration. Recovery of the granulocyte count is fairly rapid thereafter and is usually complete within another seven to fourteen days.&nbsp; If granulocytopenia with less than 1,000&nbsp;granulocytes/mm<sup>3</sup> occurs following a dose of VinBLAStine sulphate, the patient should be watched carefully for evidence of infection until the granulocyte count has returned to a safe level. Any infection must be brought under control immediately.</p><p>Patients should be carefully monitored for infection until the white cell count has returned to normal levels, if leucopoenia with less than 2000 white blood cells per mm<sup>3</sup> occurs following a dose of VinBLAStine sulphate.</p><p>&nbsp;</p><p>When cachexia or ulcerated areas of the skin are present, a more profound granulocytopenic response may be produced by VinBLAStine. Therefore, its use should be avoided in older persons suffering from either of these conditions.</p><p>&nbsp;</p><p>Although the thrombocyte count is not usually significantly lowered by therapy with VinBLAStine sulphate, patients whose bone marrow has been recently impaired by prior therapy with radiation or with other oncolytic drugs may show thrombocytopenia (less than 150,000&nbsp;platelets/mm<sup>3</sup>). When other chemotherapy or radiation has not been employed previously, thrombocyte reduction below the level of 150,000/mm<sup>3</sup> is rarely encountered, even when VinBLAStine sulphate may be causing significant granulocytopenia. Rapid recovery from thrombocytopenia within a few days is the rule.</p><p>The effect of VinBLAStine sulphate upon the red blood cell count and hemoglobin is usually insignificant when other treatment does not complicate the picture.</p><p>In patients with malignant-cell infiltration of the bone marrow, the granulocyte and platelet counts have sometimes fallen drastically after moderate doses of VinBLAStine sulphate. Further use of the drug in such patients is inadvisable.</p><p>Breaks and aberrations were not observed on chromosome analysis of marrow cells from patients treated with VinBLAStine sulphate although chromosomal changes have been noted in some hamster lung cell in vitro tests.</p><p>Granulocytes and platelet counts have sometimes fallen precipitously after moderate doses of VinBLAStine sulphate in patients with malignant cell infiltration of the bone marrow. Further use of the drug in such patients is inadvisable.&nbsp;</p><p>&nbsp;</p><p>Avoid contamination of the eye with VinBLAStine sulphate solution for injection. If accidental contamination occurs, severe irritation or corneal ulceration may result. The affected eye should be thoroughly irrigated with water immediately.</p><p><strong>&nbsp;</strong></p><p><strong>VinBLAStine</strong><strong> Sulphate contains sodium</strong></p><p>VinBLAStine sulphate contains 35.42 mg sodium in each vial, equivalent to 1.77% of the WHO maximum recommended daily intake (RDI) of 2 g sodium for an adult.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>When chemotherapy is being given in conjunction with radiation therapy through portals which include the liver, the use of VinBLAStine should be delayed until radiation therapy has been completed.</p><p>&nbsp;</p><p>VinBLAStine used as part of a combination regimen with mitomycin may result in fatal acute</p><p>respiratory distress or failure and there have been cases of pulmonary infiltration or pulmonary oedema reported.</p><p>&nbsp;</p><p>Cases of respiratory distress with interstitial pulmonary infiltrates have been reported in patients given a regimen comprising VinBLAStine, mitomycin, with or without progesterone (MVP). Acute shortness of breath and severe bronchospasm have been reported following the administration of the vinca alkaloids. These reactions have been encountered most frequently when the vinca alkaloid was used in combination with mitomycin-C and may be serious when there is pre-existing pulmonary dysfunction. The onset may be within minutes, or several hours after the vinca is injected, and may occur up to 2 weeks following a dose of mitomycin. Progressive dyspnoea, requiring chronic therapy, may occur. VinBLAStine should not be re-administered.</p><p>&nbsp;</p><p>The simultaneous administration of phenytoin and anti-neoplastic chemotherapy combinations that included VinBLAStine sulphate have been reported to reduce blood levels of the anticonvulsant and to increase seizure activity. Although the contribution of the vinca alkaloids has not been established, dosage adjustment of phenytoin, based on serial blood level monitoring, may need to be made when it is used in combination with VinBLAStine sulphate.</p><p>&nbsp;</p><p>Co-administration of cisplatin has been reported to cause higher plasma concentrations of VinBLAStine and severity of neutropenia may be altered when given in conjunction with cisplatin.</p><p><strong>&nbsp;</strong></p><p>Following combined treatment with VinBLAStine, bleomycin and cisplatin, there have been reports of a decline in glomerular filtration rate which may be reversible, nephrotoxicity, pulmonary toxicity, peripheral sensory neuropathy, neurotoxicity, ototoxicity, azoospermia, irreversible high frequency hearing loss, Raynaud&rsquo;s phenomenon with digital ischemia and gangrene, hypertension and other vascular events (such as myocardial infarction and cerebrovascular accident).</p><p><strong>&nbsp;</strong></p><p>Erythromycin may increase the toxicity of VinBLAStine which may cause increased severity of neutropenia, myalgia and constipation.</p><p>&nbsp;</p><p>Serum levels of anticonvulsants may be reduced by cytotoxic drug regimes, which include VinBLAStine.</p><p>&nbsp;</p><p>Amenorrhea has occurred in some patients treated with VinBLAStine sulphate in combination with other drugs. Recovery of menses was frequent.</p><p>There is no currently available evidence to indicate that VinBLAStine sulphate itself has been carcinogenic in humans, although some patients have developed leukaemia following radiation therapy and the administration of VinBLAStine sulphate in combination with alkylating agents.</p><p>&nbsp;</p><p>Caution should be exercised in patients concurrently taking drugs known to inhibit drug metabolism by hepatic cytochrome P450 isoenzymes in the CYP 3A subfamily, or in patients with hepatic dysfunction. Concurrent administration of VinBLAStine sulphate with an inhibitor of this metabolic pathway may cause an earlier onset and/or an increased severity of side-effects.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pregnancy</u></p><p>Although information on the use of VinBLAStine during pregnancy is limited, the drug may cause foetal toxicity when administered to pregnant women. The drug causes resorption of foetuses in animals and produces gross foetal abnormalities in surviving offspring. There are no adequate and controlled studies to date using VinBLAStine in pregnant women, and the drug should be used during pregnancy only in life-threatening situations or severe disease for which safer drugs cannot be used or are ineffective. Women of childbearing potential should be advised to avoid becoming pregnant while receiving the drug. If VinBLAStine is administered during pregnancy or the patient becomes pregnant while receiving the drug, the patient should be informed of the potential hazard to the foetus.</p><p>&nbsp;</p><p><u>Fertility</u></p><p>The effect of VinBLAStine on fertility in humans is not fully known. Aspermia has occurred in some individuals during VinBLAStine therapy.</p><p>&nbsp;</p><p><u>Breast-feeding</u></p><p>It is not known whether VinBLAStine is excreted in human milk. Because of the potential for serious adverse reactions due to VinBLAStine in nursing infants, a decision should be made whether to discontinue nursing or the drug, taking into account the importance of the drug to the mother.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The effect of VinBLAStine sulphate on the ability to drive or use machines has not been systematically evaluated.&nbsp; &nbsp;</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The use of small amounts of VinBLAStine daily for long periods is not advisable, even though the resulting total dosage may be similar to the recommended dosage. Little or no therapeutic advantage has been demonstrated when such regimens have been used and side-effects are increased.</p><p>&nbsp;</p><p>The incidence of side effects with VinBLAStine sulphate appears to be dose related and most do not persist longer than 24 hours. Neurological effects are uncommon but can occur and may last longer than 24 hours.</p><p><strong>&nbsp;</strong></p><p>The frequency grouping is defined using the following convention: Not known (cannot be estimated from the available data). Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.</p><p>&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td colspan="3" style="vertical-align:top"><p><strong>Infections and infestations</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Pharyngitis</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Neoplasms benign, malignant and unspecified (incl. cysts and polys)</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Tumour pain</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Blood and lymphatic system disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Neutropenia, Leucopenia<sup>a</sup>, Thrombocytopenia, Anaemia</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Endocrine disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Inappropriate anti-diuretic hormone secretion<sup>b</sup></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Metabolism and nutrition disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Anorexia</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Psychiatric disorders:</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Depression</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Nervous system disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Cerebrovascular accident<sup>c</sup> Convulsions, Numbness, Neuropathy peripheral, Loss of deep tendon reflexes, Paraesthesia Headache, Dizziness</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Ear and labyrinth disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>VIIIth nerve injury<sup>d</sup></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Cardiac disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Myocardial infarction<sup>c</sup></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Vascular disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Hypertension, Raynaud&rsquo;s phenomenon<sup>e</sup></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Respiratory, thoracic and mediastinal disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Dyspnoea<sup>f</sup>, Acute respiratory distress<sup>f</sup></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Gastrointestinal disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Haemorrhagic enterocolitis, Rectal bleeding, Peptic ulcer haemorrhage, Ileus, Nausea<sup>g</sup>, Vomiting<sup>g</sup>, Constipation, Oral mucosal blistering, Diarrhoea, Abdominal pain, Stomatitis</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Skin and subcutaneous tissue disorders:</strong></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td colspan="2" style="vertical-align:top"><p>Blister, Alopecia<sup>h</sup></p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Musculosketetal and connective tissue disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Not known</p></td><td colspan="2" style="vertical-align:top"><p>Myalgia,<strong> B</strong>one pain, Jaw pain</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>Reproductive system and breast disorders</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Aspermia</p></td></tr><tr><td colspan="3" style="vertical-align:top"><p><strong>General disorders and administration site conditions</strong></p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>Not known</p></td><td style="vertical-align:top"><p>Injection site phlebitis, Injection site cellulitis (and in extreme cases skin exfoliation), Extravasation, Malaise, Asthenia</p></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table><p><sup>a</sup> Leucopoenia is the most common side effect and dose limiting factor.</p><p><sup>b&nbsp; </sup>Syndrome of inappropriate ADH secretion has been reported with higher than recommended doses.</p><p><sup>c </sup>In combination chemotherapy with VinBLAStine sulphate, bleomycin and cisplatin.</p><p><sup>d </sup>Treatment with vinca alkaloids has resulted rarely in both vestibular and auditory damage to the eighth cranial nerve. Manifestations include partial or total deafness, which may be temporary or permanent, and difficulties with balance including dizziness, nystagmus, and vertigo. Particular caution is warranted when VinBLAStine sulphate is used in combination with other agents known to be ototoxic, such as the platinum-containing oncolytics.</p><p><sup>e</sup> Raynaud&rsquo;s phenomenon has occurred when patients are being treated with VinBLAStine in combination with bleomycin and cisplatin for testicular cancer.</p><p><sup>f </sup>reported when VinBLAStine is given in combinations with mitomycin (see section 4.5).</p><p><sup>g</sup> antiemetics may be used to control nausea and vomiting.</p><p><sup>h </sup>usually not total and in some cases the hair regrows during maintenance therapy).</p><p><strong>&nbsp;</strong></p><p><u>Reporting of suspected adverse reactions</u></p><p>&nbsp;</p><p>Reporting suspected adverse reactions after marketing authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions according to their local requirements.</p><p>&nbsp;</p><p><u>To report any side effect:</u></p><p><u>&nbsp;</u></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Saudi Arabia</strong></p><p>&nbsp;</p><table border="0" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>National Pharmacovigilance Centre (NPC)</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Call center: 19999</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Website: https://ade.sfda.gov.sa/&nbsp;&nbsp;</p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Other</strong><strong> GCC States</strong></p><p><strong>&nbsp;</strong></p><table border="1" cellspacing="0" cellpadding="0" style="width:100%"><tbody><tr><td style="vertical-align:top"><p>-&nbsp;&nbsp;&nbsp; <em>Please contact the relevant competent authority.</em></p></td></tr></tbody></table>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Side effects following the use of VinBLAStine are dose related. Therefore, following administration of more than the recommended dose, patients can be expected to experience these effects in an exaggerated fashion. Any dose that results in elimination of platelets and neutrophils from blood and marrow and their precursors from marrow is life-threatening.</p><p>The major effect of excessive doses of VinBLAStine will be on granulocytopoeisis, and this may be life-threatening.</p><p>&nbsp;</p><p>In addition, neurotoxicity similar to that seen with vincristine sulphate may be observed.</p><p>&nbsp;</p><p><strong>Treatment:</strong> Supportive care should include: (1) prevention of the side effects that result from the syndrome of inappropriate secretion of antidiuretic hormone. This includes restriction of fluid intake and perhaps the use of a diuretic acting on the loop of Henle and distal tubule function; (2) administration of an anticonvulsant; (3) prevention and treatment of ileus; (4) monitoring the patient&#39;s cardiovascular system; and (5) daily blood counts for guidance in transfusion requirement and assessing the risk of infection.</p><p>&nbsp;</p><p>There is no specific antidote. The use of folinic acid in addition to the other supportive measures recommended may be considered, although, unlike vincristine sulphate, studies have not been conducted to confirm its protective action.</p><p>There is no information regarding the effectiveness of dialysis nor of cholestyramine for the treatment of overdose.</p><p>VinBLAStine sulphate in the dry state is irregularly and unpredictably absorbed from the gastro‑intestinal tract following oral administration. Absorption of the solution has not been studied. If VinBLAStine sulphate is swallowed, activated charcoal in a water slurry may be given by mouth along with a cathartic. The use of cholestyramine in this situation has not been reported.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><u>Pharmacotherapeutic group: Vinca alkaloids and analogues, ATC code: L01CA01</u></p><p><u>&nbsp;</u></p><p><u>Mechanism of action</u></p><p>Although the mechanism of action has not been definitely established, VinBLAStine appears to bind to or crystallise critical microtubular proteins of the mitotic spindle, thus preventing their proper polymerisation and causing metaphase arrest. In high concentrations, VinBLAStine also exerts complex effects on nucleic acid and protein synthesis. VinBLAStine reportedly also interferes with amino acid metabolism by blocking cellular utilisation of glutamic acid and thus inhibits purine synthesis, the citric acid cycle, and the formation of urea. VinBLAStine exerts some immunosuppressive activity.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>VinBLAStine sulphate is unpredictably absorbed from the GI tract. Following intravenous administration, the drug is rapidly cleared from the blood and distributed into body tissues.</p><p>&nbsp;</p><p>VinBLAStine crosses the blood-brain barrier poorly and does not appear in the CSF in therapeutic concentrations. VinBLAStine is reported to be extensively metabolised, primarily in the liver, to desacetyl VinBLAStine, which is more active than the parent compound on a weight basis. The drug is excreted slowly in urine and in faeces via the bile.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium chloride</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Water for injections</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>VinBLAStine sulphate is incompatible with furosemide, when injected sequentially into Y-site with no flush between or when mixed in mini-bag infusion. Immediate precipitation results.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                2 years.

Do not use Vincristine sulphate after the expiry date which is stated on the Vial label after     EXP: The expiry date refers to the last day of that month.


            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store in a refrigerator (2&deg;C - 8&deg;C). Keep vial in outer carton in order to protect from light.</p><p>&nbsp;</p><p>From a microbiological point of view, the diluted product should be used immediately. If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2 to 8&deg;C, unless dilution has taken place in controlled and validated aseptic conditions.</p><p><strong>&nbsp;</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>10 ml, Type I clear conventional glass vial, rubber closure, aluminium seal with plastic flip-off top, in packs of 5 vials.</p><p>&nbsp;</p><p>10 ml, Type I clear Onco-Tain<sup>&reg;</sup> vials, rubber closure, aluminium seal with plastic flip-off top, in packs of 5 vials.</p><p>&nbsp;</p><p>Not all above presentations and pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Cytotoxic Handling Guidelines</strong></p><p>&nbsp;</p><p><strong>Administration</strong></p><p>&nbsp;</p><p>Should be administered only by or under the direct supervision of a qualified physician who is experienced in the use of cancer chemotherapeutic agents.</p><p>&nbsp;</p><p><strong>Preparation (Guidelines)</strong></p><p>&nbsp;</p><p>a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Chemotherapeutic agents should be prepared for administration only by professionals who have been trained in the safe use of the preparation.</p><p>&nbsp;</p><p>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Operations such as reconstitution of powder and transfer to mini-bags infusion should be carried out only in the designated area.</p><p>&nbsp;</p><p>c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The personnel carrying out these procedures should be adequately protected with clothing, gloves and eye shield.</p><p>&nbsp;</p><p>d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pregnant personnel are advised not to handle chemotherapeutic agents.</p><p>&nbsp;</p><p><strong>Contamination</strong></p><p>&nbsp;</p><p>a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the event of contact with the skin or eyes, the affected area should be washed with copious amounts of water or normal saline. A bland cream may be used to treat the transient stinging of skin. Medical advice should be sought if the eyes are affected.</p><p>&nbsp;</p><p>b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the event of spillage, operators should put on gloves and mop up the spilled material with a sponge kept in the area for that purpose. Rinse the area twice with water. Put all solutions and sponges into a plastic bag and seal it.</p><p>&nbsp;</p><p><strong>Disposal</strong></p><p>&nbsp;</p><p>Mini-bags infusion, containers, absorbent materials, solution and any other contaminated material should be placed in a thick plastic bag or other impervious container and incinerated.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                MARKETING AUTHORISATION HOLDER
Hospira UK Limited
Horizon
Honey Lane
Hurley 
Maidenhead
SL6 6RJ, UK

MANUFACTURER 
Hospira Australia Pty Ltd MULGRAVE, Australia

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                	July 2023
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>